Highlights

  • WHO said it cannot ‘cut corners' in considering emergency-use listing for Covaxin
  • WHO has asked for more data from Bharat Biotech
  • Travel plans will get complicated for those who have taken Covaxin without WHO nod

 

Latest news

Omicron scare: Maharashtra man tests Covid +ve after returning from South Africa

Omicron scare: Maharashtra man tests Covid +ve after returning from South Africa

India mandates 14-day travel history, negative RT-PCR test for international arrivals from Dec 1

India mandates 14-day travel history, negative RT-PCR test for international arrivals from Dec 1

BJP wins big in Tripura, bags 329 out of 334 seats in municipal elections

BJP wins big in Tripura, bags 329 out of 334 seats in municipal elections

Salman Khan fans pour milk on 'Antim' poster, actor says give it to the poor

Salman Khan fans pour milk on 'Antim' poster, actor says give it to the poor

'Acharya' teaser: Ram Charan looks fierce as Siddha in the Chiranjeevi-starrer

'Acharya' teaser: Ram Charan looks fierce as Siddha in the Chiranjeevi-starrer

'Cannot cut corners': WHO on approving India's Covaxin shot

Without a WHO nod, the two-dose Covaxin is unlikely to be accepted as a valid vaccine around the world and would complicate travel plans for Indians who have taken it.

The World Health Organization on Monday said it cannot ‘cut corners' in considering Bharat Biotech’s request for an emergency-use listing for its COVID-19 shot.

Further, the world health body has asked for more data from Bharat Biotech which started sharing data with the WHO from early July.

Also Read Covid Complications: The higher the BMI, the bigger the risk

Bharat Biotech’s Covid-19 vaccine, Covaxin was given emergency-use authorisation in India in January even before the completion of a late-stage trial, which later found the shot to be 78% efficacious.

Without a WHO nod, the two-dose Covaxin is unlikely to be accepted as a valid vaccine around the world and would complicate travel plans for Indians who have taken it.

Covaxin accounts for 11% of the 985.5 million total doses administered in India

India is the world’s biggest producer of vaccines, with a capacity to make more than 3 billion COVID shots a year.

Up Next

'Cannot cut corners': WHO on approving India's Covaxin shot

'Cannot cut corners': WHO on approving India's Covaxin shot

India mandates 14-day travel history, negative RT-PCR test for international arrivals from Dec 1

India mandates 14-day travel history, negative RT-PCR test for international arrivals from Dec 1

BJP wins big in Tripura, bags 329 out of 334 seats in municipal elections

BJP wins big in Tripura, bags 329 out of 334 seats in municipal elections

PM skips all party meet, Oppn demands MSP law, compensation for farmers

PM skips all party meet, Oppn demands MSP law, compensation for farmers

Omicron variant | Govt to review decision to resume international flights

Omicron variant | Govt to review decision to resume international flights

Omicron variant | Intensive containment, active surveillance, increased vaccination: Centre to states

Omicron variant | Intensive containment, active surveillance, increased vaccination: Centre to states

More videos

'I am done! Goodbye! INJUSTICE': comedian Munawar Faruqui hints at quitting comedy
Pandemic is not over yet, warns PM Modi as new variant raises concerns
Experts' description of 'Omicron' variant raises concern
Heavy rains continue to lash Chennai, intensity to reduce from Sunday predict weather experts
PM Modi to chair all-party meet ahead of winter session; repeal to crypto - a heavy agenda ahead
Variant scare pushes states to issue new rules for travellers, here is what you need to know
Delhi Choking: Records highest pollution days in November with AQI severe for 11 days
Legislature does not assess impact of laws before passing them: Chief Justice
Farmer unions suspend November 29 tractor rally to Parliament
Bad vaccination figures can’t be hidden behind one man’s photo: Rahul Gandhi